SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

MSI NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

NOVARTIS: Click to view the issuer\'s details

Last update : 28/01/2011  >View issuer details

2017.03.22 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis provides update on Phase III study of RLX030 (serelaxin) in patients with acute heart failure - HTML (w)

2017.03.21 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis' Cosentyx is first and only IL-17A inhibitor to potentially modify the course of psoriasis - HTML (w)

2017.03.13 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Sandoz announces winners of inaugural Healthcare Access Challenge (Sandoz HACk) - HTML (w)

2017.03.06 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis' Cosentyx shows almost all psoriasis patients rapidly regain skin clearance following a treatment pause - HTML (w)

2017.03.06 | 07:10 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine - HTML (w)

2017.02.23 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis drug Zykadia receives FDA Priority Review for first-line use in patients with ALK+ metastatic NSCLC - HTML (w)

2017.01.31 | 07:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Novartis drug Votubia® receives EU approval to treat refractory partial-onset seizures in patients with TSC - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 871